How long does an Ultomiris infusion take?
In general, minimum infusion times for Ultomiris (ravulizumab) can range from 0.4 hours to 3.8 hours. The infusion time is based on the patient’s weight, the prescribed dose and if it is a loading dose or maintenance dose. Ultomiris is given through a vein as an intravenous (IV) infusion. Patients are also monitored for at least one hour after the IV infusion for allergic-type infusion reactions.
Refer to the manufacturer’s product labeling for the tables detailing the minimum infusion times for Ultomiris.
The first two infusions are usually given 2 weeks apart, followed by an infusion once every 4 or 8 weeks, based on body weight. Only use Ultomiris as directed by your doctor. If you miss an appointment for your Ultomiris infusion, call your doctor right away.
Ultomiris is approved by the FDA for the treatment of adults with paroxysmal nocturnal hemoglobinuria (PNH) and the treatment of adults and pediatric patients 1 month of age and older with atypical hemolytic uremic syndrome (aHUS).
This is not all the information you need to know about Ultomiris (ravulizumab) for safe and effective use and does not take the place of your doctor’s directions. Review the full product information and discuss this information and any questions you have with your doctor or other health care provider.
Related medical questions
- How does Ultomiris compare to Soliris for PNH?
- How long does an Ultomiris infusion take?
- How does Ultomiris compare to Soliris for PNH?
- How long does an Ultomiris infusion take?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions